Angiographic and Intravascular Ultrasound (IVUS) Follow-up After Simultaneously Implanted Different Drug-eluting Stents in Same Individuals
- Conditions
- Drug Eluting Stent
- Registration Number
- NCT00973375
- Lead Sponsor
- Liuhuaqiao Hospital
- Brief Summary
The purpose of this study is to investigate if there is any different follow-up results by angiography and IVUS between two different drug-eluting stents after implanted simultaneously in same individuals.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- These patients who received two kinds of drug-eluting stent (Endeavor and Excel) im simultaneously.
Exclusion Criteria
- Dual anti-platelet therapy less than 12 months.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Segment and instent restenosis measured by coronary angiography and IVUS. at 12 months after implantation
- Secondary Outcome Measures
Name Time Method Uncovered and malposition of stent. at 12 months after implantation.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of drug-eluting stents in coronary artery disease?
How do drug-eluting stents compare to bare-metal stents in long-term restenosis prevention?
Which biomarkers predict optimal response to drug-eluting stent therapy in patients with atherosclerosis?
What are the known adverse events associated with different drug-eluting stent coatings and how are they managed?
What are the current combination therapies involving drug-eluting stents for complex coronary lesions?
Trial Locations
- Locations (1)
Liuhuaqiao Hospital
🇨🇳Guangzhou, Guangdong, China
Liuhuaqiao Hospital🇨🇳Guangzhou, Guangdong, China